Literature DB >> 17142405

The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease.

Ph Hernigou1, A Habibi, D Bachir, F Galacteros.   

Abstract

BACKGROUND: Osteonecrosis of the femoral head is a frequent complication in adult patients with sickle cell disease. However, little is known about the natural history of asymptomatic lesions.
METHODS: One hundred and twenty-one patients (121 hips) with sickle cell disease and asymptomatic osteonecrosis of the femoral head that was contralateral to a hip with symptomatic osteonecrosis were identified with magnetic resonance imaging between 1985 and 1995. The lesions were graded with use of the Steinberg classification system. The patients were followed with annual plain radiographs. The mean duration of follow-up was fourteen years.
RESULTS: At the time of the initial evaluation, fifty-six hips were classified as Steinberg stage 0, forty-two hips were classified as Steinberg stage I, and twenty-three hips were classified as Steinberg stage II. At the time of the most recent follow-up, pain had developed in 110 previously asymptomatic hips (91%) and collapse had occurred in ninety-three hips (77%). Symptoms always preceded collapse. Of the fifty-six hips that were classified as Steinberg stage 0 at the time of the initial evaluation, forty-seven (84%) had symptomatic osteonecrosis and thirty-four (61%) had collapse at the time of the most recent follow-up. Of the forty-two asymptomatic stage-I hips, forty (95%) became symptomatic within three years and thirty-six (86%) had collapse of the femoral head. Of the twenty-three asymptomatic stage-II hips, all became symptomatic within two years and all collapsed; the mean interval between the onset of pain and collapse was eleven months. At the time of the final follow-up, ninety-one hips (75%) had intractable pain and required surgery.
CONCLUSIONS: Untreated asymptomatic osteonecrosis of the femoral head in patients with sickle cell disease has a high likelihood of progression to pain and collapse. Because of the high prevalence of complications after total hip arthroplasty in patients with this disease, consideration should be given to early surgical intervention with other procedures in an attempt to retard progression of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 17142405     DOI: 10.2106/JBJS.E.01455

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  50 in total

1.  Untreated asymptomatic hips in patients with osteonecrosis of the femoral head.

Authors:  Byung-Woo Min; Kwang-Soon Song; Chul-Hyun Cho; Sung-Moon Lee; Kyung-Jae Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-08       Impact factor: 4.176

Review 2.  What is the optimal imaging of osteonecrosis, Perthes, and bone infarcts?

Authors:  Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2009-04

3.  Tardive hip disease diagnosis in a young adult with sickle cell disease.

Authors:  A A Bokolombe; F Samato; T Lukinu; M B Ekila; M N Aloni
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

4.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

5.  Pathophysiology and risk factors for osteonecrosis.

Authors:  Kalpit N Shah; Jennifer Racine; Lynne C Jones; Roy K Aaron
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

6.  Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis.

Authors:  Thorsten M Seyler; David R Marker; Slif D Ulrich; Tobias Fatscher; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-05       Impact factor: 4.176

7.  Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review.

Authors:  Jean-Cyr Yombi; Bernard Vandercam; Dunja Wilmes; Jean-Emile Dubuc; Anne Vincent; Pierre-Louis Docquier
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

Review 8.  Imaging of musculoskeletal manifestations in sickle cell disease patients.

Authors:  Vijaya Kosaraju; Alok Harwani; Sasan Partovi; Nicholas Bhojwani; Vasant Garg; Sabarish Ayyappan; Christos Kosmas; Mark Robbin
Journal:  Br J Radiol       Date:  2017-03-10       Impact factor: 3.039

9.  [Osteonecrosis after chemotherapy in children].

Authors:  B Westhoff; M Jäger; R Krauspe
Journal:  Orthopade       Date:  2008-01       Impact factor: 1.087

10.  Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease.

Authors:  Ehud Lebel; Mici Phillips; Deborah Elstein; Ari Zimran; Menachem Itzchaki
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.